Here are six takeaways:
1. Factors fueling market growth include a growing prevalence of chronic diseases and an increasing aging population.
2. Medical implant advancements and heightened awareness about artificial implants are also driving market growth.
3. On the other hand, implantation’s high costs, insufficient reimbursement policies and a gap in skilled healthcare professionals may hinder market growth.
4. Currently, North America dominates the market due to its medical technological advancements, increasing aging population, rising healthcare expenditures, growing prevalence of chronic diseases and better healthcare infrastructure.
5. Asia is likely to grow through 2021 due to more awareness surrounding therapeutic medical implant applications, a growing aging population, more chronic diseases, increasing disposable income as well as developing healthcare infrastructure.
6. Market vendors include Johnson & Johnson, Abbott Laboratories, Edwards Life-sciences, Orthofix, Novartis, Sorin, Boston Scientific, Smith & Nephew, Tornier and Stryker.
More device news:
North America, Europe lead orthopedic imaging market through 2026: 5 notes
Quantum computing, robotics & more — Which technologies will change healthcare by 2025?
Wearable medical devices market to hit $8.44B by 2020 — 6 observations
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
